GS 5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) in Chronic Genotype 1 Hepatitis C Virus (HCV) Infection

Mount Sinai Medical Center, New York

University of Pennsylvania Hospital, Philadelphia

Walter Reed Army Medical Center, Washington D.C.

Johns Hopkins University, Lutherville

Inova Fairfax Hospital - Center for Liver Diseases, Falls Church

Liver Institute of Virginia, Bon Secours Health System, Newport News

Duke University Medical Center, Durham

Gastrointestinal Specialists of Georgia PC, Marietta

Borland-Groover Clinic, Jacksonville

University of Florida - Gainesville, Gainesville

Orlando Immunology Center, Orlando

Orlando Clinical Research Center, Orlando

University of Miami School of Medicine, Miami

Bach and Godofsky Infectious Diseases, Bradenton

Birmingham Gastroenterology Associates, P.C., Birmingham

Digestive Health Specialists of the Southeast, Dothan

Columbia Medical Group, The Frist Clinic, Nashville

Nashville Gastrointestinal Specialists, Inc, Nashville

Gastro One, Germantown

Memphis Gastroenterology Group, Germantown

Gastrointestinal Associates, PA, Jackson

Cleveland Clinic, Cleveland

Indiana University, Indianapolis

Henry Ford Health System, Detroit

University of Chicago, Chicago

Private Practice, Opelousas

Options Health Research, LLC, Tulsa

Baylor University Medical Center, Dallas

Research Specialists of Texas, Houston

Alamo Medical Research, San Antonio

Lifetree Clinical Research, LC, Salt Lake City

University of New Mexico, Albuquerque

University of California San Diego, San Diego

Southern California Liver Centers, Coronado

Kaiser Permanente, San Diego

Advanced Clinical Research Institute, Anaheim

UCSF Fresno Medical Education Program (MEP), Fresno

UCSF, San Francisco

Stanford University School of Medicine, Palo Alto

Massachusetts General Hospital, Boston

Beth Israel Deaconess Medical Center, Boston

University of North Carolina at Chapel Hill, Chapel Hill

Fundacion de Investigacion de Diego, San Juan